U.S. FDA advisers to discuss COVID vaccine boosters in April

The U.S. drug regulator said on Monday a panel of independent advisers will meet on April 6 to discuss considerations for use of COVID-19 vaccine booster doses.

The U.S. Food and Drug Administration said no vote was planned at this meeting and there will not be any discussion of any of the COVID vaccine makers' applications for additional boosters.